Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Critical Care (London, England)|February 21, 2024
Novel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trialNarges Alipanah-Lechner, James Hurst-Hopf, Kevin Delucchi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 17, 2023
Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDSNarges Alipanah-Lechner, Lucile Neyton, Eran Mick, et al.
British Journal of Clinical Pharmacology|August 15, 2025
Dose individualisation of antibiotics in critically ill patients with inflammation: A narrative reviewSarah Dräger, Iris K Minichmayr, Narges Alipanah-Lechner, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2025
Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injuryVaibhav Upadhyay, Edwin F Ortega, Luis A Ramirez Hernandez, et al.
American Journal of Respiratory and Critical Care Medicine|January 19, 2024
The Plasma Lipidomic Landscape in Patients with Sepsis due to Community-acquired PneumoniaOsoul Chouchane, Alex R Schuurman, Tom D Y Reijnders, et al.
Critical Care Medicine|October 28, 2025
Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With SepsisMelanie F Weingart, Andrew Willmore, Hanjing Zhuo, et al.
The Journal of Clinical Investigation|December 2, 2025
Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify pathways associated with mortalityNarges Alipanah-Lechner, Lucile Neyton, Pratik Sinha, et al.
Medrxiv : the Preprint Server for Health Sciences|September 18, 2025
Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify key pathways associated with mortalityNarges Alipanah-Lechner, Lucile Neyton, Pratik Sinha, et al.
American Journal of Respiratory and Critical Care Medicine|July 29, 2025
Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)Michael A Matthay, Hanjing Zhou, Aartik Sarma, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Lipid mobilization establishes metabolic tolerance and prevents autonomic collapse in infectionAnkita Sarkar, Shangkui Xie, Syed Muhammad Musa Ali Rizvi, et al.
Pageof 2